InsidersTradesSigma
Track the RELAY THERAPEUTICS INC share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €4.3bn. The latest transaction was reported on 26 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: PETER RAHMER. The full history is openly available.
Analysts rate RELAY THERAPEUTICS INC Strong Buy (bullish), based on 13 analysts. Average price target: US$27.08.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
RELAY THERAPEUTICS INC 是一家生物制药公司，专注于开发用于治疗癌症和其他疾病的靶向疗法。它利用先进技术来加强药物发现。